O Hikmat1,2, C Tzoulis2,3, P M Knappskog2,4, S Johansson4,5,6, H Boman2,4, P Sztromwasser4, E Lien7, E Brodtkorb8,9, D Ghezzi10, L A Bindoff2,3. 1. Department of Paediatrics, Haukeland University Hospital, Bergen, Norway. 2. Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway. 3. Department of Neurology, Haukeland University Hospital, Bergen, Norway. 4. Centre for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway. 5. Department of Biomedicine, University of Bergen, Bergen, Norway. 6. K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway. 7. Department of Paediatrics, St Olav's University Hospital Trondheim, Trondheim, Norway. 8. Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. 9. Department of Neurology and Clinical Neurophysiology, St Olav's University Hospital, Trondheim, Norway. 10. Unit of Molecular Neurogenetics, Foundation IRCCS Neurological Institute 'Carlo Besta', Milan, Italy.
Abstract
BACKGROUND AND PURPOSE: Defects of coenzyme Q10 (CoQ10) metabolism cause a variety of disorders ranging from isolated myopathy to multisystem involvement. ADCK3 is one of several genes associated with CoQ10 deficiency that presents with progressive cerebellar ataxia, epilepsy, migraine and psychiatric disorders. Diagnosis is challenging due to the wide clinical spectrum and overlap with other mitochondrial disorders. METHODS: A detailed description of three new patients and one previously reported patient from three Norwegian families with novel and known ADCK3 mutations is provided focusing on the epileptic semiology and response to treatment. Mutations were identified by whole exome sequencing and in two measurement of skeletal muscle CoQ10 was performed. RESULTS: All four patients presented with childhood-onset epilepsy and progressive cerebellar ataxia. Three patients had epilepsia partialis continua and stroke-like episodes affecting the posterior brain. Electroencephalography showed focal epileptic activity in the occipital and temporal lobes. Genetic investigation revealed ADCK3 mutations in all patients including a novel change in exon 15: c.T1732G, p.F578V. There was no apparent genotype-phenotype correlation. CONCLUSION: ADCK3 mutations can cause a combination of progressive ataxia and acute epileptic encephalopathy with stroke-like episodes. The clinical, radiological and electrophysiological features of this disorder mimic the phenotype of polymerase gamma (POLG) related encephalopathy and it is therefore suggested that ADCK3 mutations be considered in the differential diagnosis of mitochondrial encephalopathy with POLG-like features.
BACKGROUND AND PURPOSE: Defects of coenzyme Q10 (CoQ10) metabolism cause a variety of disorders ranging from isolated myopathy to multisystem involvement. ADCK3 is one of several genes associated with CoQ10 deficiency that presents with progressive cerebellar ataxia, epilepsy, migraine and psychiatric disorders. Diagnosis is challenging due to the wide clinical spectrum and overlap with other mitochondrial disorders. METHODS: A detailed description of three new patients and one previously reported patient from three Norwegian families with novel and known ADCK3 mutations is provided focusing on the epileptic semiology and response to treatment. Mutations were identified by whole exome sequencing and in two measurement of skeletal muscle CoQ10 was performed. RESULTS: All four patients presented with childhood-onset epilepsy and progressive cerebellar ataxia. Three patients had epilepsia partialis continua and stroke-like episodes affecting the posterior brain. Electroencephalography showed focal epileptic activity in the occipital and temporal lobes. Genetic investigation revealed ADCK3 mutations in all patients including a novel change in exon 15: c.T1732G, p.F578V. There was no apparent genotype-phenotype correlation. CONCLUSION:ADCK3 mutations can cause a combination of progressive ataxia and acute epilepticencephalopathy with stroke-like episodes. The clinical, radiological and electrophysiological features of this disorder mimic the phenotype of polymerase gamma (POLG) related encephalopathy and it is therefore suggested that ADCK3 mutations be considered in the differential diagnosis of mitochondrial encephalopathy with POLG-like features.
Authors: Adel Shalata; Michael Edery; Clair Habib; Jacob Genizi; Mohammad Mahroum; Lama Khalaily; Nurit Assaf; Idan Segal; Hoda Abed El Rahim; Hana Shapira; Danielle Urian; Shay Tzur; Liza Douiev; Ann Saada Journal: Neurochem Res Date: 2019-04-09 Impact factor: 3.996
Authors: Jessie C Jacobsen; Whitney Whitford; Brendan Swan; Juliet Taylor; Donald R Love; Rosamund Hill; Sarah Molyneux; Peter M George; Richard Mackay; Stephen P Robertson; Russell G Snell; Klaus Lehnert Journal: JIMD Rep Date: 2017-11-21
Authors: Anna Chang; Marta Ruiz-Lopez; Elizabeth Slow; Mark Tarnopolsky; Anthony E Lang; Renato P Munhoz Journal: Mov Disord Clin Pract Date: 2018-10-09
Authors: Juan Carlos Rodríguez-Aguilera; Ana Belén Cortés; Daniel J M Fernández-Ayala; Plácido Navas Journal: J Clin Med Date: 2017-03-05 Impact factor: 4.241
Authors: Andreas Traschütz; Tommaso Schirinzi; Lucia Laugwitz; Nathan H Murray; Craig A Bingman; Selina Reich; Jan Kern; Anna Heinzmann; Gessica Vasco; Enrico Bertini; Ginevra Zanni; Alexandra Durr; Stefania Magri; Franco Taroni; Alessandro Malandrini; Jonathan Baets; Peter de Jonghe; Willem de Ridder; Matthieu Bereau; Stephanie Demuth; Christos Ganos; A Nazli Basak; Hasmet Hanagasi; Semra Hiz Kurul; Benjamin Bender; Ludger Schöls; Ute Grasshoff; Thomas Klopstock; Rita Horvath; Bart van de Warrenburg; Lydie Burglen; Christelle Rougeot; Claire Ewenczyk; Michel Koenig; Filippo M Santorelli; Mathieu Anheim; Renato P Munhoz; Tobias Haack; Felix Distelmaier; David J Pagliarini; Hélène Puccio; Matthis Synofzik Journal: Ann Neurol Date: 2020-06-10 Impact factor: 11.274